|
|
Stanton J. Rowe
Corporate Vice President, Advanced Technology and Chief Scientific Officer, Edwards Lifesciences
Stanton J. Rowe has been chief scientific officer since 2008 and also serves as corporate vice president, advanced technology. He joined the company in 2004 when Edwards acquired Percutaneous Valve Technology, of which he was president and CEO and helped to found in 1999. Previously, Rowe was corporate vice president of business development and strategic planning for Datascope and was vice president of business development for Johnson & Johnson’s interventional systems division (JJIS), responsible for the company’s coronary stent development efforts. At JJIS and the related Cordis Corporation, Rowe held a variety of positions with increasing levels of responsibility, including heading the company’s business development, advanced technology, worldwide clinical research, and marketing groups. Rowe joined Cordis after having held several positions in product management for various medical device companies. He is on the board of directors of both Remon Medical Ltd. and Biomerix. Rowe received his bachelor’s degree from the University of Alabama. |
